Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.975 USD | -0.07% |
|
+1.78% | -9.01% |
25/06 | Oppenheimer Initiates Coverage on Adverum Biotechnologies With Outperform Rating, $25 Price Target | MT |
11/06 | Adverum Biotechnologies, Inc. Announces Executive Changes | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.01% | 145M | |
+16.06% | 122B | |
+18.99% | 113B | |
+18.95% | 26.49B | |
-23.41% | 19.4B | |
-19.03% | 16.24B | |
-19.91% | 15.4B | |
-46.14% | 15.15B | |
+64.34% | 14.93B | |
+5.31% | 13.52B |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.
- Transcript : Adverum Biotechnologies, Inc. - Special Call